|Articles|July 25, 2017
Novartis Contracts with Cryoport to Support Novartis Cell Therapies
Advertisement
Novartis has signed an aggreement contracting Cryoport-provider of logistics solutions for biopharmaceutical, IVF, and animal health organizations globally-over an initial three-year tern for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
3
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
4
After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
